0001493152-21-016710.txt : 20210713 0001493152-21-016710.hdr.sgml : 20210713 20210713145542 ACCESSION NUMBER: 0001493152-21-016710 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210713 DATE AS OF CHANGE: 20210713 EFFECTIVENESS DATE: 20210713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Voltron Therapeutics, Inc. CENTRAL INDEX KEY: 0001835742 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-406044 FILM NUMBER: 211087651 BUSINESS ADDRESS: STREET 1: 575 FIFTH AVE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (212) 953-4936 MAIL ADDRESS: STREET 1: 575 FIFTH AVE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 D 1 primary_doc.xml X0708 D LIVE 0001835742 Voltron Therapeutics, Inc. 12 E 49TH STREET 11TH FLOOR NEW YORK NY NEW YORK 10017 646-335-5923 DELAWARE None None Corporation true 2017 Patrick Gallagher 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Executive Officer Director Chief Executive Officer Matthew Duffy 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Executive Officer Director President James Ahern 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Director Paul Korner 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Director Anthony Zook 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Director Matthew Eitner 12 E 49th Street 11th Floor New York NY NEW YORK 10017 Director Pharmaceuticals Decline to Disclose 06b false 2019-10-31 false true true false 0 Laidlaw & Company (UK) Ltd. 119037 None None 521 FIFTH AVENUE, 12TH FLOOR NEW YORK NY NEW YORK 10175 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA ID IDAHO IL ILLINOIS LA LOUISIANA MA MASSACHUSETTS NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO OK OKLAHOMA PA PENNSYLVANIA TX TEXAS WI WISCONSIN true 3349428 3349428 0 false 49 402000 true 0 283500 true false Voltron Therapeutics, Inc. /s/ Matthew Duffy Matthew Duffy President 2021-07-13